https://www.selleckchem.com/pr....oducts/selonsertib-g
However, the number of oocytes retrieved (5 (0-16) vs. 4 (0-15), = .006), mature oocytes (4 (0-15) vs. 3 (0-11), = .032), and blastocysts obtained (70 vs. 53) were substantially greater after LPS. The DuoStim strategy in poor prognosis patients increases the number of oocytes and blastocysts available. Moreover, the number of oocytes and blastocysts obtained are higher after LPS when compared to FPS. Thus, it should be considered for selected patients in order to not only improve reproductive outcomes but also shorten the